Q&A - Economic analyses for vaccine introduction decisions in low- and middle- income countries
Initiative for Vaccine Research, World Health Organization, 20 Avenue Appia, CH-1211, Geneva, Switzerland
BMC Medicine 2013, 11:71 doi:10.1186/1741-7015-11-71Published: 14 March 2013
First paragraph (this article has no abstract)
Raymond Hutubessy is a senior health economist affiliated to the Immunization, Vaccines and Biologicals (IVB) Department of the World Health Organization (WHO), and is the executive secretary of the WHO Immunization and Vaccines related Implementation Research Advisory Committee (IVIR-AC). His main research interests focus on economic and financial analyses of vaccine introduction decisions in low- and middle-income countries (LMICs). In this Q&A, he will discuss the importance of this work in relation to the global context of vaccine introduction decisions (Figure 1).